- Home
- BFZ vs OSUR Comparison
BFZ vs OSUR Comparison
Compare BFZ & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFZ
- OSUR
- Stock Information
- Founded
- BFZ 2001
- OSUR 2000
- Country
- BFZ United States
- OSUR United States
- Employees
- BFZ N/A
- OSUR N/A
- Industry
- BFZ Finance Companies
- OSUR Medical/Dental Instruments
- Sector
- BFZ Finance
- OSUR Health Care
- Exchange
- BFZ Nasdaq
- OSUR Nasdaq
- Market Cap
- BFZ 340.9M
- OSUR 284.9M
- IPO Year
- BFZ N/A
- OSUR 1986
- Fundamental
- Price
- BFZ $11.20
- OSUR $3.38
- Analyst Decision
- BFZ
- OSUR Hold
- Analyst Count
- BFZ 0
- OSUR 2
- Target Price
- BFZ N/A
- OSUR $5.50
- AVG Volume (30 Days)
- BFZ 60.7K
- OSUR 1.0M
- Earning Date
- BFZ 01-01-0001
- OSUR 02-25-2025
- Dividend Yield
- BFZ 4.39%
- OSUR N/A
- EPS Growth
- BFZ N/A
- OSUR N/A
- EPS
- BFZ 0.08
- OSUR N/A
- Revenue
- BFZ N/A
- OSUR $185,827,000.00
- Revenue This Year
- BFZ N/A
- OSUR N/A
- Revenue Next Year
- BFZ N/A
- OSUR $8.41
- P/E Ratio
- BFZ $147.26
- OSUR N/A
- Revenue Growth
- BFZ N/A
- OSUR N/A
- 52 Week Low
- BFZ $9.86
- OSUR $2.69
- 52 Week High
- BFZ $12.31
- OSUR $7.20
- Technical
- Relative Strength Index (RSI)
- BFZ 40.86
- OSUR 43.32
- Support Level
- BFZ $11.17
- OSUR $3.18
- Resistance Level
- BFZ $11.34
- OSUR $3.54
- Average True Range (ATR)
- BFZ 0.09
- OSUR 0.22
- MACD
- BFZ -0.02
- OSUR -0.02
- Stochastic Oscillator
- BFZ 9.33
- OSUR 49.64
About BFZ BlackRock California Municipal Income Trust
Blackrock CA Muni Income Tr is a United States-based closed-end management investment company. The investment objective of the trust is to provide current income exempt from regular U.S. federal income tax. The trust seeks to achieve its investment objectives by investing a majority of its total assets in municipal bonds.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.